Last update 08 Apr 2025

Teriparatide Acetata(Sawai Pharmaceutical)

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms-
Target
PTH1R
Action
agonists
Mechanism
PTH1R agonists(Parathyroid hormone receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases
Active Indication
Osteoporosis
Inactive Indication-
Originator Organization
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd.
Active Organization
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (17 Jun 2022),
Osteoporosis
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with Teriparatide Acetata(Sawai Pharmaceutical)
JPRN-UMIN000023344
/ CompletedNot ApplicableIIT
The efficacy of teriparatide for the bone strength of patients suffered proximal femoral fracture, evaluated by computed tomographic finite element analysis - The efficacy of teriparatide for the bone strength of patients suffered proximal femoral fracture, evaluated by computed tomographic finite element analysis
JPRN-UMIN000022598
/ SuspendedNot ApplicableIIT
Study on inhibitory effect of teriparatide in knee osteoarthritis - Inhibitory effect of teriparatide in knee osteoarthritis
JPRN-UMIN000020584
/ CompletedNot ApplicableIIT
Comparative effect of daily teriparatide, weekly teriparatide, or bisphosphonate on bone microarchitecture in patients with primary osteoporosis: A HR-pQCT study - Comparative effect of daily teriparatide, weekly teriparatide, or bisphosphonate in patients with primary osteoporosis
100 Clinical Results associated with Teriparatide Acetata(Sawai Pharmaceutical)
Login to view more data
100 Translational Medicine associated with Teriparatide Acetata(Sawai Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with Teriparatide Acetata(Sawai Pharmaceutical)
Login to view more data
100 Deals associated with Teriparatide Acetata(Sawai Pharmaceutical)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoporosis
Japan
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd.
17 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
WCO_IOF_ESCEO2023
Not Applicable
Back Pain | Spinal Fractures
200
rnldlpkblm(rpedchjvzo) = Wedge type qpvuxxkzzn (gokhmogpwi )
Positive
04 May 2023
WCO_IOF_ESCEO2023
Not Applicable
Osteoporotic Fractures
415
nzfsahrnpa(jirtksonnp) = mgyqodusea fnzsfdwvfg (ywpxjyleqs )
Positive
04 May 2023
Placebo
nzfsahrnpa(jirtksonnp) = xyzmvejdgs fnzsfdwvfg (ywpxjyleqs )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free